A review of antiepileptic drugs: Part 1 occurrence, fate in aquatic environments and removal during different treatment technologies

Antiepileptic drugs (AEDs) arc the main treatment for people with epilepsy. However, in recent years, more and more people are using them for other indications such as: migraine, chronic neuropathic pain, and mood disorders. Consequently, the prescriptions and consumption of these drugs are increasing worldwide. In WWTPs, AEDs can resist degradation processes, such as photodegradation, chemical degradation and/or biodegradation. Until now, only constructed wetlands and photocatalysis have shown good removal rates of AEDs from wastewater. However, their effectiveness depends on the specific conditions used during the treatment. Since the consumption of AEDs has increased in the last decade and their degradation in WWTPs is poor, these drugs have been largely introduced into the environment through the discharge of municipal and/or hospital effluents. Once in the environment, AEDs are distributed in the water phase, as suspended particles or in the sediments, suggesting that these drugs have a high potential for groundwater contamination. In this first part of the AEDs review is designed to fill out the current knowledge gap about the occurrence, fate and removal of these drugs in the aquatic environment. This is a review that emphasizes the characteristics of AEDs as emerging contaminants. (C) 2021 Elsevier B.V. All rights reserved.

Automated summary

Antiepileptic drugs (AEDs) are increasingly used for indications beyond epilepsy treatment, leading to a global rise in their prescriptions and consumption. However, the removal efficiency of these drugs in wastewater treatment plants is low, posing a potential risk of groundwater contamination.